Inventor · disambiguated record
Marcos Sainz
Also filed as: SAINZ MARCOS · SAINZ MARCOS ADRIAN
12 granted patents·10 pending applications·8 citations·filing 2020–2024
84Inventor score
Top patents by PatentIndex Score
22 records- 0194US11919864B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·3 cites·52 claims
- 0294US11667636B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·3 cites·32 claims
- 0389US11952346B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Apr 9, 2024·1 cites·11 claims
- 0488US11970452B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Apr 30, 2024·1 cites·4 claims
- 0585US12129243B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·11 claims
- 0684US12129244B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·36 claims
- 0784US2025026735A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0881US12384748B2Modulators of mas-related g-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Granted Aug 12, 2025·0 cites·10 claims
- 0981US2025289815A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1080US2024300907A1Modulators of mas-related g-protein receptor x4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1180US2024059667A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1276US12275707B2Modulators of mas-related g-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Apr 15, 2025·0 cites·42 claims
- 1376US12240845B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·0 cites·41 claims
- 1476US11840521B2Modulators of Mas-related G-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2022·Granted Dec 12, 2023·0 cites·32 claims
- 1574US2024239749A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1673US11643399B2Modulators of mas-related G-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted May 9, 2023·0 cites·23 claims
- 1765US2024246980A1Modulators of mas-related g-protein receptor d and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1865US2021032213A1Modulators of mas-related g-protein receptor x4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1961US2024182460A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 2058US11787767B2Modulators of mas-related g-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Oct 17, 2023·0 cites·8 claims
- 2158US2024018115A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 2256US2024254089A1Modulators of mas-related g-protein receptor x4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marcos Sainz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →